Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online March 24, 2020.
Article Versions
- Latest version (March 24, 2020 - 04:00).
- You are currently viewing a Latest version of this article (March 24, 2020 - 06:45).
- latest version (April 15, 2020 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2020 The Journal of Rheumatology
Author Information
- Randy Q. Cron and
- W. Winn Chatham
- From the Department of Pediatrics, Division of Rheumatology (RQC) and the Department of Medicine, Division of Clinical Immunology and Rheumatology (WWC), University of Alabama at Birmingham.
Dr. Cron serves as a consultant to Novartis, Pfizer, and SOBI. Dr. Chatham has served as a consultant to Novartis and SOBI.
Drs. Cron and Chatham are co-Principal Investigators on an investigator initiated clinical trial to study interleukin-1 blockade in treating secondary hemophagocytic lymphohistiocytosis in children and adults that is funded by Swedish Orphan Biovitrum, Inc. (SOBI) [NCT02780583].
Address correspondence to Randy Q. Cron, MD, PhD, Children’s of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, suite G10, Birmingham, AL 35233-1711. E-mail: rcron@peds.uab.edu.